Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ge Lan Xiang oral solution
- Development stage
- Unknown
- Lead developer
- Harbin Medical University Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Ge Lan Xiang oral solution is a Traditional Chinese Medicine (TCM) product developed and manufactured by Harbin Medical University Pharmaceutical Co., Ltd. It is a Chinese patent medicine formulated to treat the common cold, influenza, and upper respiratory tract infections, particularly when presenting with the TCM pattern of "wind-heat with internal food stagnation." The solution is composed of several botanical extracts, most notably Puerariae Lobatae Radix (Ge Gen), Isatidis Radix (Ban Lan Gen), and Pogostemonis Herba (Guang Huo Xiang), which collectively exert antipyretic, antiviral, and digestive-regulating effects. It is widely used in China, particularly in pediatric populations, and has been the subject of Phase IV clinical trials to further validate its safety and efficacy in real-world clinical settings.
- Brand names
- Ge Lan Xiang
- Other names
- 格蓝香口服液Gelanxiang oral solution
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Ge Lan Xiang oral solution.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ge Lan Xiang oral solution.